Visitor Monitoring Drug History: ZOCOR
 
Drugs Directory of False Positives DRUGS THAT CAUSES A FALSE POSITIVE ON A DRUG TEST
 
Browse by Letter: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Label and Approval History

Drug Name: ZOCOR
FDA Application No: (NDA) 019766
Active Ingredient(s): SIMVASTATIN
Company: MERCK
 
Label History
 
View the label approved on June 4, 2007 for ZOCOR, (NDA) 019766


To see older, previously-approved labels, go to the "Approval History" section of this page. Older labels are for historical information only and should not be used for clinical purposes.
 
 
 
Approval History
 
Action DateSupplement NumberSort imageApproval TypeLetters, Reviews, Labels, Patient Package Insert
6/1/2007 074Control Supplement Letter
Label 
5/17/2005 070Labeling Revision Letter
Label 
8/31/2005 069Labeling Revision Letter
Label 
2/25/2004 068Supplement Letter
Label
Review 
2/24/2004 067Labeling Revision Letter
Label
Review 
9/17/2003 066Labeling Revision Letter
Label 
9/17/2003 065Labeling Revision Letter
Label 
4/16/2003 058New or Modified Indication Letter
Label
Review 
5/6/2002 057Control Supplement  
10/18/2002 056Patient Population Altered Letter
Label 
2/22/2002 055Manufacturing Change or Addition  
3/21/2002 054Package Change  
11/14/2001 053Labeling Revision Label 
3/21/2002 052Efficacy Supplement with Clinical Data to Support Letter
Label
Review 
5/6/2002 051Labeling Revision Letter
Label 
9/13/2001 050Control Supplement  
6/4/2001 049Control Supplement  
4/10/2001 048Manufacturing Change or Addition  
4/10/2001 047Manufacturing Change or Addition  
11/14/2001 045Labeling Revision  
12/11/2000 044Package Change  
4/14/2000 043Manufacturing Change or Addition  
11/7/2000 042Efficacy Supplement with Clinical Data to Support  
3/15/2000 041Control Supplement  
4/27/2000 040New Dosage Regimen Letter
Label
Review 
8/22/2000 039Labeling Revision  
11/22/1999 036New or Modified Indication Review 
9/15/1999 035Labeling Revision  
11/22/1999 034New or Modified Indication Review 
3/22/1999 033Expiration Date Change  
8/5/1999 032New or Modified Indication Letter 
4/23/1999 031Labeling Revision  
9/24/1998 030Manufacturing Change or Addition  
6/29/1998 029Labeling Revision Review 
7/10/1998 028New Dosage Regimen Letter
Review 
3/31/1998 027New or Modified Indication Letter
Review 
7/10/1998 026New or Modified Indication Letter
Review 
12/2/1997 025Control Supplement  
9/9/1997 023Control Supplement  
7/18/1997 022Manufacturing Change or Addition  
10/31/1997 021New or Modified Indication  
8/12/1997 020Labeling Revision  
3/17/1997 019Control Supplement  
5/19/1997 018Labeling Revision Review 
5/23/1997 017Labeling Revision  
11/22/1996 016Control Supplement  
8/1/1995 015Labeling Revision  
6/9/1995 014Labeling Revision  
11/6/1995 013Control Supplement  
8/1/1995 012Control Supplement  
6/30/1995 011New or Modified Indication  
2/16/1995 010Labeling Revision  
12/21/1994 009Labeling Revision  
4/19/1995 008Labeling Revision  
7/28/1994 007Manufacturing Change or Addition  
1/23/1995 006Labeling Revision  
2/22/1994 005Labeling Revision  
11/24/1993 004Package Change  
2/22/1994 003Labeling Revision  
8/9/1993 002Package Change  
11/27/1992 001Labeling Revision  
12/23/1991 000Approval Other Important Information from FDA 
 
©2019 Drugs That Causes a False Positive on a Drug Test